Annual report pursuant to Section 13 and 15(d)

SEGMENT INFORMATION (Details)

v3.8.0.1
SEGMENT INFORMATION (Details) - USD ($)
12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Revenues $ 1,077,550 $ 616,446
Depreciation 181,637 26
Interest expenses 138,110
Net income (loss) (4,049,645) 55,581
Identifiable long-lived tangible assets 7,671,786 295
Real property operating [Member]    
Revenues 828,663
Depreciation 86,135
Interest expenses 138,110
Net income (loss) (309,415)
Identifiable long-lived tangible assets 7,645,371
Medical related consulting services [Member]    
Revenues 222,611 616,446
Depreciation 8,774 26
Interest expenses
Net income (loss) (385,515) 55,581
Identifiable long-lived tangible assets 20,558 295
Development services and sales of developed products[Member]    
Revenues 26,276
Depreciation 86,728
Interest expenses
Net income (loss) (1,463,401)
Identifiable long-lived tangible assets 5,857
Others [Member]    
Net income (loss) [1] $ (1,891,314)
[1] The Company does not allocate any general and administrative expense of its being a public company activities to its reportable segments as these activities are managed at a corporate level.